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Perspectives in the Study of Thyroid Hormone Action on
Brain Development and Function
Juan Bernal, Ana Guadaño-Ferraz, and Beatriz Morte
The purpose of this review is to provide an up-to-date report on the molecular and physiologic processes in-
volved in the role of thyroid hormone as an epigenetic factor in brain maturation. We summarize the available
data on the control of brain gene expression by thyroid hormone, the correlation between gene expression and
physiologic effects, and the likely mechanisms of action of thyroid hormone on brain gene expression. In ad-
dition we propose a role for unliganded thyroid hormone receptors in the pathogenesis of hypothyroidism. Fi-
nally, we review recent data indicating that thyroid hormone receptors have an impact on behavior.
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Introduction
BRAIN DEVELOPMENT proceeds through precisely coordi-nated events in time and space. Induction of neural tis-
sue, differentiation and migration of specific cell types, 
regional specialization or synapse formation are major mile-
stones in a myriad of intricately associated events. Most of
these events are largely determined by genetic factors (1).
However, epigenetic factors, such as the thyroid hormones,
are also important because they act to control the timing and
coordination of mechanistically unrelated processes. For
many years thyroid hormone has been considered essential
for brain maturation in humans and other mammals. Defi-
ciency of thyroid hormones during critical periods of devel-
opment leads to profound and potentially irreversible de-
fects of brain maturation (2,3), and clinical syndromes arising
from thyroid hormone deficiency during fetal and postnatal
periods have been extensively reviewed elsewhere (3,4).
The brain as a target of thyroid hormone
Most of the available evidence supports the view that thy-
roid hormone does not influence the major early develop-
mental processes such as neural induction, neurulation, and
establishment of polarity and segmentation. Thyroid hor-
mone is involved in regulation of later events, such as cell
migration and the formation of cortical layers, and in neu-
ronal and glial cell differentiation. Thus, as a consequence of
thyroid hormone deficiency during specific fetal stages, al-
tered cell migration in the neocortex results in less defined
cortical layering and altered distribution of callosal connec-
tions (5). Deficiencies of cell migration are also observed in
the hippocampus, resulting in lower number of granule cells
in the dentate gyrus. A defining feature of neonatal hy-
pothyroidism is the delayed migration of granule cells in the
cerebellum, which results in abnormal persistence of the ex-
ternal germinal layer.
Thyroid hormone also controls differentiation of not only
neurons and oligodendrocytes (6), but also astrocytes, and
microglia (7,8). Specific neuronal cell types are characteristi-
cally affected by hypothyroidism, such as pyramidal cells of
the neocortex and Purkinje cells of the cerebellum. The lat-
ter show a strong dependence of thyroid hormone, because
in its absence they do not fully develop their characteristic
highly elaborated dendritic tree. On the other hand, lack of
proper differentiation of oligodendrocytes results in myeli-
nation deficits.
Deiodinases and the control of triiodothyronine
concentrations in the brain
The main active thyroid hormone is triiodothyronine (T3),
which in the brain derives in large part from 59 deiodination
of thyroxine (T4). This pathway is closely regulated by de-
velopmental and physiologic factors (9). Concentrations of
T3 in the brain are the result of transfer to the brain through
the blood-brain barrier, by a poorly defined mechanism, and
the local activities of deiodinases 2 (D2) and 3 (D3). D2 gen-
erates T3 from T4 by phenolic ring deiodination, whereas D3
inactivates T4 and T3 by tyrosil ring deiodination with gen-
eration of the inactive products reverse triiodothyronine
(rT3) and 3,39 triiodothyronine (T2), respectively. Expression
of D2 and D3 in the brain is developmentally regulated. In
the rat, D2 activity is low during the fetal period, and in-
creases postnatally, whereas D3 follows the opposite pattern
(10). D3 activity is high in placenta and in fetal tissues and
high activity has been detected in the uterine implantation
site (11). This pattern of expression suggests a protective role
during development. In agreement with this, recent data
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have shown that inactivation of the D3 gene leads to partial
lethality at birth and severe growth impairment (12). It may
also be that D3 expression and the regulation of T3 genera-
tion and its subsequent availability to target cells is a way to
control the timing of thyroid hormone signaling in a fashion
similar to the control of amphibian metamorphosis (13). In
adult animals D3 is diffusely expressed in neurons through-
out the brain (14). In contrast, during the late fetal and early
postnatal period, D3 mRNA is highly concentrated in dis-
crete nuclei such as the bed nucleus of stria terminalis, cen-
tral amygdala, and the preoptic area (15). These nuclei are
involved in sexual differentiation of the brain during the
early postnatal period, but the functional significance for the
restricted expression of D3 in these nuclei is not known.
D2 activity increases during the postnatal period and is
sensitive to thyroid hormone concentrations. In hypothy-
roidism, its increased activity tends to normalize T3 concen-
trations even with greatly reduced T4 concentrations. In con-
trast with D3, which is expressed in neurons, D2 is expressed
in two types of glial cells (16,17). The highest expression is
found in the tanycytes, a specialized type of glial cells that
line the lower third of the walls of the third ventricle. These
cells send processes to the adjacent hypothalamus where
they frequently end in blood vessels, and to the median em-
inence, ending in portal vessels. Thus, D2 in these cells could
be involved in providing T3 to the cerebrospinal fluid (CSF)
from which it would reach nearby structures by diffusion,
and/or the portal blood, influencing pituitary function. Stim-
ulation of D2 in the tanycytes by cytokines with subsequent
local production of T3 and inhibition of thyrotropin (TSH)
secretion has been recently suggested to play a role in non-
thyroidal illness (18). D2 is also expressed throughout the
brain in astrocytes and in some interneurons (19). Astrocytes
appear therefore to have an active role not only in the 
uptake of T4 from the blood through the blood-brain bar-
rier, but also in generating T3 and delivering it to nearby 
neurons.
Molecular basis of thyroid hormone action on brain
development
Many of the effects of thyroid hormone on developmen-
tal processes in the brain can be correlated with the con-
trolled expression of specific molecules. The most obvious is
myelination, which is secondary to the effects of thyroid
hormone on oligodendrocyte differentiation and the expres-
sion of oligodendrocyte specific genes (20). Lack of thyroid
hormone during the postnatal period in rats, at the time of
onset of myelination, strongly delays the expression of many
oligodendrocyte genes, specifically the genes encoding pro-
teins of myelin such as myelin basic protein (MBP), prote-
olipid protein (PLP), and myelin-associated glycoprotein
(MAG) (21). As a result, the number of myelinated axons in
hypothyroid rats is strongly reduced (22).
How thyroid hormone influences differentiation of neural
cells is poorly understood. It has been suggested that T3 is
an instructive factor in the early steps of oligodendrocyte
generation from stem cells, and that it controls the timing of
oligodendrocyte precursor cell differentiation (23,24). It has
also recently been shown that T3 promotes neuronal differ-
entiation of embryonic stem cells in culture (25). The inti-
mate molecular mechanisms by which thyroid hormone pro-
motes differentiation is unknown. Molecular suspects in-
clude proteins regulating the cell cycle, such as E2F-1 (see
Billon et al. [24]), p53, cyclins and cyclin-dependent kinase
inhibitors (26). Thyroid hormone control of neurotrophin ex-
pression, especially NGF, BDN, and NT-3, may provide also
an explanation for its effects on differentiation of particular
cells, such as cholinergic neurons and Purkinje cells (27). In
many cases the effects of thyroid hormone on differentiation
are subtle but with potentially important functional conse-
quences. For example, in hypothyroidism there is a de-
creased number of dendritic spines in pyramidal cells of the
neocortex and hippocampus, which is reversible and also ob-
served after adult-onset hypothyroidism (28). Although the
gross morphology of the neurons is not appreciably modi-
fied, changes in spine density have strong consequences on
synaptic plasticity. The mechanisms by which dendritic
spines are affected by thyroid hormone are unknown.
RC3/neurogranin (29), a dendritic spine protein is under
thyroid hormone control, both in developing and in adult
animals (30), but it is not known whether expression of this
protein is related to spine formation.
Proper migration of neurons depends on the interaction
of cell surface receptors with proteins present in the extra-
cellular matrix. One of these proteins, reelin (31), is regulated
by thyroid hormone during the late prenatal and early post-
natal life in the rat (32). Reelin expression is essential for the
orderly migration of neurons to their specific destinations in
the cerebral and cerebellar cortices, and determines the nor-
mal pattern of cortical layers. This protein is produced by
Cajal-Retzius cells, which express another thyroid hormone-
regulated gene, prostaglandin D2 synthase (33). Other mol-
ecules reported to be involved in cell migration, such as
laminin, tenascin C, and L1, are also under thyroid hormone
control (34,35).
Most of the actions of thyroid hormone are exerted via nu-
clear receptors, which are ligand-modulated transcription
factors. The physiologic ligand is T3, and therefore it is con-
sidered to be the active form of thyroid hormone. Because
T4 has low affinity for the nuclear receptors, it might be con-
sidered as a prohormone, whose role would be to deliver T3
intracellularly through 59 deodination. There are, however,
data suggesting that T4 may have actions of its own. It reg-
ulates D2 activity in astrocytes and has a direct action on F-
actin polymerization (36,37). Also in astrocytes, T4 has been
shown to influence integrin-laminin interactions (38), an im-
portant process in cell migration.
Whether these nongenomic actions of T4 actually contrib-
ute in vivo to the effects of thyroid hormone on neural cell
migration is however unknown. Work by Davis et al. (39)
also suggests that T4 has biologic activity per se. In this case,
the action of T4 is mediated via the microtubule-associated
protein (MAP) kinase pathway and phosphorylation of the
T3 receptor and other targets (39). So far it is not known how
this activity of T4 may contribute to the overall physiologic
activities of the thyroid hormones. With respect to the nonge-
nomic actions, mice deficient in all forms of nuclear T3 re-
ceptors have no signs of hyperthyroidism in the face of
highly elevated circulating T4 and T3, suggesting that most
effects of thyroid hormone are mediated through the nuclear
receptors (40). Therefore, the contribution of nongenomic ac-
tions to the overall effects of thyroid hormone is not yet clear.
Davis and Davis (41) have suggested that at least for the
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heart, nongenomic actions of thyroid hormone determine the
basal activity of transporters and ion channels. If this con-
cept is extrapolated to the brain, the nongenomic actions of
thyroid hormone could be important in neurotransmission.
Another long-standing controversial topic is the role of the
mitochondria in the overall effects of thyroid hormone in
brain and other tissues (4,42). It is clear that thyroid hormone
influences mitochondrial function indirectly through the con-
trol of nuclear-encoded mitochondrial genes. In addition, the
expression of mitochondrial-encoded genes are also influ-
enced by the thyroidal status, and T3 has direct actions on
isolated mitochondria in vitro (43). Therefore, direct effects of
T3 on the mitochondria in vivo appear likely. Truncated forms
of TRa1 and RXRa have been described in the mitochondria
(44), and it is proposed that T3 may affect mitochondrial tran-
scription in a way similar to the action on the nucleus. These
topics have been recently reviewed in detail (45).
Patterns and mechanisms of gene regulation by thyroid
hormone in the brain
During the past 10 years, we and others have identified a
number of genes under thyroid hormone control in the brain
(for a review, see Bernal [4]). This list of genes is likely to be
greatly enlarged when global analysis of gene expression us-
ing cDNA arrays technologies are used to identify thyroid
hormone target genes. Most of the genes identified so far are
expressed and regulated by thyroid hormone during the
postnatal period (Fig. 1), and the role of thyroid hormone is
to accelerate the normal physiologic process of upregulation
or downregulation that these genes experience after birth. A
good example is provided by the myelin genes, which are
induced a few days after birth, in parallel with the timing of
oligodendrocyte differentiation and the myelination wave.
In the absence of thyroid hormone, accumulation of myelin
gene products, mRNA, and protein proceeds at a slower rate,
and final normal concentrations are attained but later in de-
velopment than in normal animals. Other genes show a re-
gion-specific dependence of T3. One example is RC3. This
gene is expressed in subsets of neurons of the cerebrum, and
thyroid hormone is needed to achieve normal expression in
discrete regions such as layer VI of the neocortex and retro-
splenial region, caudate nucleus, and dentate gyrus. The
gene is expressed in other regions such as the upper layers
of neocortex, and pyramidal cells of hippocampus, but it is
not sensitive to thyroid hormone in these locations despite
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FIG. 1. Thyroid hormone-regulated genes in rat brain. The dependency of gene expression on thyroid hormone supply is
represented schematically along a time line from conception (C) through embryonic (E) and postnatal (P) development.
Birth is indicated by P0. Most genes are affected by the thyroidal status only during a limited period of development, which
is indicated by the horizontal bars. NGF, TrkA, and RC3 are also thyroid hormone-dependent during adult life. A few genes,
such as those encoding NSP-A, Oct-1, and RC3 have also been shown to be regulated during embryonic development. The
inset delimited by the discontinuous lines illustrates the regional and temporal pattern of thyroid hormone regulation of
myelin genes which follows the myelination wave, from the caudal to rostral regions. BS, brain stem; CB, cerebellum; MB,
midbrain; Hipp, hippocampus. At the bottom of the figure, the approximate time of first detection of TRa and of TRb, the
appearance of the thyroid gland, and the peak generation of neurons, astrocytes and oligodendrocytes. Modified from Bernal
(42) with permission from Elsevier.
the presence of T3 receptors. Because RC3 is regulated by T3
directly at the transcriptional level (46,47), the most likely ex-
planation for such a region-specific control is that regulation
of this gene is based on a combinatorial distribution of tran-
scription factors, including T3 receptors. Therefore, in sensi-
tive regions, T3 receptors might complement the pool of tran-
scription factors needed for target gene expression.
Another example of region-specific control is ZAKI-4. This
gene encodes a calcineurin inhibitor expressed throughout
the brain (48), but sensitive to T3 only in layer VI of neocor-
tex. Regulation of this gene by T3 is indirect because it re-
quires new protein synthesis. In this case, it is likely that in
layer VI, T3 regulates expression of a protein required for
ZAKI-4 expression. Recent evidence suggests that the mech-
anism of ZAKI-4 induction by thyroid hormone involves ac-
tivation of phosphoinositide-3 kinase (49).
The temporal patterns of thyroid hormone-dependent gene
expression in the brain suggest that the critical period of thy-
roid hormone sensitivity is limited to the first 2–3 postnatal
weeks in the rat. In humans the sensitive period would cor-
respondingly start after midpregnancy. However, there may
be a bias in this concept, derived from the fact that most
searches for thyroid hormone-dependent genes in the brain
have been made during the postnatal period, at the peak of T3
receptor expression and occupancy. From the data illustrated
in Figure 1, it can be seen that the period of thyroid hormone
sensitivity for some genes extends to the adult period (RC3,
TrkA, and NGF) whereas for others it starts during the fetal
period (tenascin C, L1, reelin). Earlier ages were not analyzed.
In other studies (50,51) it was found that maternal hormones
influenced fetal brain expression of RC3, NSP-A, and Oct-1.
Maternal hormones have recently been demonstrated to play
an important role in cell migration in the fetal neocortex (52).
The application of global analysis of gene expression using
suitable models of fetal hypothyroidism may help to identify
T3-regulated genes during fetal brain development.
The primary action of thyroid hormone on gene expres-
sion is mediated through interaction of the T3 receptors with
responsive elements located in gene regulatory regions (53).
Some of the genes known to be responsive to thyroid hor-
mone in the brain contain triiodothyronine response elements
(TREs) and in some cases the action of T3 has been shown to
be at the transcriptional level in vitro. Genes containing TREs
in their promoter or intronic regions include those encoding
myeline basic protein (54), the Purkinje cell-specific gene
(PCP2) (55), which encodes a G protein nucleotide exchange
factor (56), the calmodulin binding and protein kinase C
(PKC) substrate RC3 (47), prostaglandin D2 synthetase (57,58)
the transcription factor hairless (59), the neuronal cell adhe-
sion molecule (NCAM) (60), and the early response gene
NGFI-A (61). Expression of other genes are regulated at the
levels of mRNA stability (acetyl cholinester-ase), protein
translation (MAP2), or mRNA splicing (tau). Regulation of
splicing might be indirect, and subsequent to a primary ac-
tion on the transcription of splicing regulators (62).
Role of thyroid hormone receptors
In mammals, T3 receptors are the products of two genes
known as TRa and TRb that encode nine protein products
that arise by alternative splicing and differential promoter
usage. The TRa gene encodes five protein products (TRa1,
TRa2, TRa3, and the truncated products DTRa1 and DTRa2)
from which only TRa1 binds T3. The TRb gene encodes four
T3 binding proteins, of which TRb1, TRb2, and TRb3 also bind
to responsive elements in DNA. In addition, a truncated pro-
tein, DTRb3 binds T3 but not DNA. It may be said, therefore,
that there are two types of receptors, a and b, and four dif-
ferent receptor isoforms. The physiologic role of the nonre-
ceptor proteins is at present still unclear.
Concerning whether different receptor isoforms subserve
different physiologic functions by selectively regulating spe-
cific genes, the current view is that the receptor isoforms are
mostly equivalent in their biologic activity in vivo, including
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TABLE 1. THYROID HORMONE-DEPENDENT BRAIN GENES CONTAINING T3-RESPONSIVE ELEMENTS
Gene product Expression in brain Biochemical function Location of TRE
Myelin basic protein Oligodendrocytes Structural protein of Promoter region
(MBP) myelin sheaths
Purkinje cell protein 2 Cerebellar Purkinje cells G protein nucleotide Promoter region and 
(PCP-2) exchange factor intron
Neurogranin (RC3) Neurons Calmodulin-binding and protein First intron
kinase C-specific substrate
Lipocalin-type Leptomeninges, schoroid Generates prostaglandin Upstream promoter 
Prostaglandin D2 plexus, some neurons D2 from prostaglandin H. region
synthase (b-trace) and oligodendrocytes Transport of lipophilic substances
Hairless Neurons Transcription factor Promoter region
Neuronal cell Neurons Adhesion molecule Intron D
adhesion molecule 
(NCAM)
NGFI-A (egr-1, zif268) Neurons Early response transcription factor Promoter region
T3, triiodothyronine; TRE, triiodothyronine response elements.
binding affinity for T3 (63), and that the different physiologic
roles of each receptor depends on their particular patterns of
expression. Thus, TRb is involved in regulation of pituitary,
liver, and cochlear function, whereas TRa regulates cardiac
function, body temperature, gut maturation, and lymphocyte
development. These specific effects of each receptor type are
mainly due to their tissue distribution. In the cerebellum, TRa
is expressed in the granular cells, whereas TRb is expressed
in the Purkinje cells. Therefore, it is not surprising that the ef-
fects of T3 on migration if granular cells is mediated by TRa,
whereas those on differentiation of Purkinje cells are medi-
ated by TRb (64). Another recent example (see below) is the
finding of quantitative differences in TRa1 and TRb1 expres-
sion among subsets of GABAergic interneurons of the cere-
bral cortex and hippocampus, which is correlated with effects
on behavior (65). A different case has been made on the con-
trol of thermogenesis in brown adipose tissue, where the use
of the TRb-selective ligand GC-1 has allowed to define spe-
cific functions for TRa1 and TRb1 (66).
A prominent role of TRa1 in brain development and func-
tion may be deduced from its relative expression in cere-
brum and cerebellum, accounting for approximately 70%–
80% of total T3 receptor binding (67). Given the widespread
distribution of T3 receptors in the brain it is noteworthy that
mutant mice lacking TRa1, TRb, or both, do not display ob-
vious signs of developmental abnormalities. One possible ex-
planation for this paradox is that in the absence of ligand,
transcriptional repression or abnormal regulation of tran-
scription by the unliganded receptor is responsible for the
effects of profound hypothyroidism. This is supported by
two lines of evidence. One was provided by Samarut et al.
(68), which showed that congenitally hypothyroid, Pax 8-de-
ficient mice, which die during the first weeks of life, can be
rescued by TRa1 gene deletion. Other evidence was pro-
vided by our group in studies on cerebellar development in
TRa1-deficient mice (64). In these studies we showed that
contrary to what happens in wild-type mice, the mutant mice
do not show delayed granular cell migration and arrested
Purkinje cell differentiation after induction of neonatal hy-
pothyroidism. It appears, therefore, that these cerebellar al-
terations which constitute one of the hallmarks of neonatal
hypothyroidism in rodents are the result of negative influ-
ences of the unliganded TRa1 cerebellar expression of a mu-
tated form of TRb1 with dominant negative activity strongly
arrested Purkinje cell differentiation (69).
Role of thyroid hormone receptors in behavior
As pointed out above, absence of thyroid hormone recep-
tors is not associated with obvious developmental alter-
ations. The possibility exists, however, that absence of re-
ceptor during development may lead to subtle alterations
derived from disturbances in correct maturation of specific
neurons. A role of TRa1 in early neuronal differentiation has
been suggested from studies using stem cells in culture
(25,70). It is likely that receptor deficiency is therefore asso-
ciated with alterations in differentiation or migration of se-
lected neuronal groups leading to subtle anomalies of brain
function, not easily related to receptor function. Behavioral
analysis of receptor-deficient mice may disclose alterations
not previously expected on the basis of the known classical
THYROID ACTION IN BRAIN 1009
FIG. 2. Behavior of adult TRa1-deficient mice (solid boxes)
in the open field (A) and the contextual (B) and cued (C) fear
conditioning tests. The behavior of control wild-type mice is
represented in open boxes. In the open field test the animals
were placed in the center of a circular open field of 140 cm
diameter and 32 cm height, and the behavior and locomotor
activity were videotaped. A significant number of TRa1-de-
ficient mice stayed motionless (freezing), displayed less rear-
ing, and spent less time in the center area of the field than
the wild-type mice. The fear conditioning tests took place in
Pavlovian conditioning cages. In this context, fear condi-
tioning, which depends on the integrity of both amygdala
and hippocampus, the mice learn to associate the context
with an aversive stimulus (i.e., an electric shock). Extinction
of the response took much more time for the TRa1 knockout
mice. In cued-fear conditioning, a test that depends on the
integrity of the amygdala, the mice learn to associate the
aversive stimulus with a cue, usually a sound. In this test,
both learning (24-hour test) and the extinction of the re-
sponse (1 week) were similar in knockout and wild-type
mice. The results suggested a lesion at the level of the hip-
pocampus, and were correlated with a decreased number of
GABAergic terminals in the CA1 field. Reproduced from
Guadaño-Ferraz et al. (65) with permission.
effects of thyroid hormone. TRb-deficient mice did not pres-
ent any alterations in several tests including the open field
test, the Morris water maze test, or contextual fear condi-
tioning tests (71). However, female mice with deletions of ei-
ther TRa1 or TRb1 show opposite response to estrogens on
sex behavior (72): absence of TRb1 led to an increase sexual
behavior, whereas absence of TRa1 reduced sexual behavior.
In other terms, ligand-activated TRb1 would be an inhibitor
of sexual response, whereas liganded TRa1 would have the
opposite function. The data for TRb1 fit with results from
Pfaff and coworkers (73) that showed that thyroid hormone
may interfere with the actions of estrogens on female sex re-
sponses. At the molecular level it was shown that TR may
interfere with estrogen induction of responsive genes by in-
teractions at the level of the estrogen responsive elements of
target genes (73). The fact that TRa1 behaved differently than
TRb1 in these behavioral paradigms may be because of ad-
ditional roles of TRa1 in other forms of behavior.
We have analyzed whether deletion of TRa1 would lead
to behavioral alterations in adult mice using several behav-
ioral tests (65), the first of which was the open-field test to
assess locomotor behavior in a new environment. In this test
the animals were more prone to display “freezing,” (i.e., to
stay motionless) (Fig. 2). This indicated that the mice had
high emotionality. In a second battery of tests, the animals
learn to associate an innocuous stimulus (the conditional
stimulus), which might be either the context (as in contex-
tual fear conditioning) or a cue, for example a sound (as is
cued fear conditioning), with an aversive stimulus (uncon-
ditional stimulus) that is usually an electric shock delivered
through metal rods in the cage floor. As shown in Figure 2,
there were no differences in behavior at 24 hours of train-
ing. However, the extinction of the response was surpris-
ingly delayed in the context fear conditioning test. In other
words, TRa1-deficient mice have a reduced capacity to for-
get negative memories. The results of these experiments,
combined with data on the microstructure of the hippocam-
pus and cerebral cortex, as well as the cellular distribution
of thyroid hormone receptors have led us to hypothesize that
TRa1 is involved in the specification of hippocampal neu-
ronal circuits involved in behavior (65).
Conclusions
From the data accumulated during the past 10 years, we
are starting to understand the general features of thyroid
hormone action in the brain in molecular terms. Knowledge
in this field has, however, had a very strong limitation be-
cause of the complexity of the target organ under study,
which requires the convergence of several disciplines. In ad-
dition to a more precise understanding of the classic effects
of thyroid hormone deficiency or excess, the analysis of mice
with genetically altered thyroid hormone receptors are pro-
viding surprising and unexpected results. In particular, the
notion that some features of the hypothyroid phenotype may
be the result of altered transcriptional regulation by the un-
liganded receptors more than to the lack of hormone per se.
In addition, the indication that thyroid hormone receptors
may have a role in behavior opens new fields of inquiry and
raises the intriguing possibility that receptor mutations may
underlie psychiatric forms of behavior in humans.
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